Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction

Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction

To assess the long-term effects of tadalafil, a therapeutic agent for fetal growth restriction (FGR), we evaluated the developmental progress of 1.5-year-old infants whose mothers had taken tadalafil during pregnancy. Twenty-four infants were assessed. We evaluated infant body weight, height, and he...

Full description

Bibliographic Details
Main Authors: Shintaro Maki, Ineko Kato, Naosuke Enomoto, Sho Takakura, Masafumi Nii, Kayo Tanaka, Hiroaki Tanaka, Shinsuke Hori, Kana Matsuda, Yukito Ueda, Hirofumi Sawada, Masahiro Hirayama, Akihiro Sudo, Tomoaki Ikeda
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Journal of Clinical Medicine
Subjects:
FGR
PDE5 inhibitor
tadalafil
KSPD
Online Access:https://www.mdpi.com/2077-0383/9/5/1448

Internet

https://www.mdpi.com/2077-0383/9/5/1448

Similar Items